(Q72130727)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8061170%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

title

Recency, duration, and progestin content of oral contraceptives in relation to the incidence of endometrial cancer (Washington, USA) (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8061170%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

1 reference

3

N S Weiss

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8061170%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

1

L F Voigt

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8061170%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

author name string

Q Deng

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8061170%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

publication date

1 May 1994

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8061170%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

published in

Cancer Causes & Control

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8061170%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8061170%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8061170%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

page(s)

227-233

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8061170%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf01830241

24 October 2019

exact match

0 references

cites work

Potency of progestogens in oral contraceptives--further delay of menses data

1 reference

12 December 2020

Pharmacokinetics of three bioequivalent norethindrone/mestranol-50 micrograms and three norethindrone/ethinyl estradiol-35 micrograms OC formulations: are "low-dose" pills really lower?

1 reference

12 December 2020

Hormonal content of combined oral contraceptives in relation to the reduced risk of endometrial carcinoma. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives

1 reference

12 December 2020

Progestagen supplementation of exogenous oestrogens and risk of endometrial cancer

1 reference

12 December 2020

Relative potency of progestins used in oral contraceptives

1 reference

12 December 2020

Oral contraceptives and the risk of endometrial cancer

1 reference

12 December 2020

Decreased Risk of Endometrial Cancer among Oral-Contraceptive Users

1 reference

12 December 2020

The epidemiology of endometrial cancer in young women

1 reference

12 December 2020

Menstruation span--a time-limited risk factor for endometrial carcinoma

1 reference

12 December 2020

Protection against endometrial carcinoma by combination-product oral contraceptives

1 reference

12 December 2020

Breast cancer and oral contraceptives: critique of the proposition that high potency progestogen products confer excess risk

1 reference

12 December 2020

Endometrial cancer and combined oral contraceptives. The Who Collaborative Study of Neoplasia and Steroid Contraceptives

1 reference

12 December 2020

Progestational potency of oral contraceptives

1 reference

12 December 2020

Hormone balance of oral contraceptives

1 reference

12 December 2020

Oral contraceptives and endometrial cancer: do other risk factors modify the association?

1 reference

12 December 2020

Incidence of endometrial cancer in relation to the use of oral contraceptives

1 reference

12 December 2020

Oral contraceptives and cancers of the breast and of the female genital tract. Interim results from a case-control study

1 reference

12 December 2020

Potencies of oral contraceptives

1 reference

12 December 2020

Combination oral contraceptive use and the risk of endometrial cancer. The Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development

1 reference

12 December 2020

A case-control study of cancer of the endometrium

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01830241

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8061170%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

1 reference